NAVETA network
Real-world evidence with PROMs and PREMs
NAVETA is a real-world evidence network based on patient-reported outcome and experience measures (PROMs and PREMs), promoted by FARUPEIB.
A value-based telemedicine platform that integrates patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) into hospital pharmaceutical care. NAVETA enables systematic, longitudinal monitoring of health-related quality of life in chronic diseases.
New · November 2026
NAVETA collaboration dossier
What NAVETA is, the network in figures, how it works and three ways to collaborate: research, health outcomes reports and training in PROMs and PREMs. For hospitals, professionals and industry.
Open the dossier (in Spanish) →Objectives
- Implement systematic collection of PROMs/PREMs through telepharmacy
- Enable value-based pharmaceutical care for patients with chronic conditions
- Monitor quality of life longitudinally with PROMs and PREMs
- Pilot AI-based support tools (Mateu Orfila, Inca and Manacor), always validated by the pharmacist
- Reduce unnecessary hospital visits through telemedicine
Therapeutic areas
- Psoriasis / Atopic dermatitis
- Pharmaceutical care in HIV
- Inflammatory bowel disease
- Rheumatoid arthritis
- Multiple sclerosis
- Migraine
- Ophthalmology (DME, AMD)
- Obesity
- Oncology
Recent awards
- Premio a la mejor comunicación científica · 71 Congreso Nacional SEFH · SEFH · NAVETA · semantic analysis of patient messages
- Premio Gala de la Salut 2026 · Conselleria de Salut del Govern Balear · NAVETA
- Accésit Premios Novartis-IESE a la excelencia operativa en gestión sanitaria 2026 · IESE (CRHIM) / Novartis · NAVETA Dermatología
Key publications
Implementing Systematic Patient-Reported Measures Through the Naveta Value-Based Telemedicine Initiative
JMIR Mhealth Uhealth. 2024;12:e56196
Person-centred coordinated care experience measured by the P3CEQ
Health Serv Insights. 2024;13:11786329241258856
TELEPROM Psoriasis: Enhancing patient-centered care and HRQoL
Front Med (Lausanne). 2024;11:1465725
Developing a Prototype Machine Learning Model to Predict QoL in People Living With HIV
Integr Pharm Res Pract. 2025;14:1-16
